News
STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma's Pharmaceutical Prescription and Consumer Health Business
The STADA Group continues its growth trajectory in Europe. The company, announced that it is acquiring the pharmaceutical business of Biopharma, one of the key pharmaceutical producers in Ukraine.
Is veganism good for your health?
The Future of Your Health report indicates that nearly a third of Brits don’t think so
ALVOTECH AND STADA AGREE ON STRATEGIC BIOSIMILAR PARTNERSHIP
Biopharmaceutical company Alvotech and global pharmaceutical company STADA Arzneimittel AG ("STADA") today announced that they have entered into an exclusive strategic partnership for the commercialisation of seven biosimilars in all key European markets and selected markets outside Europe.
STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets
STADA to acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, Georgia and CIS countries
STADA to acquire Walmark - a leading Consumer Healthcare company in Central Europe
STADA Arzneimittel AG ('STADA' or 'the Group') today announces the acquisition of Walmark a.s. ('Walmark' or 'the company') from Mid Europa Partners for an undisclosed consideration.
Q&A 2019 Pharmacy Show
A Q&A Session with Phoebe Buckley on the 2019 Pharmacy Show
STADA Health Report 2019
More than half of people in UK are optimistic about the future of health
Leading pharmaceutical company invests in seven-figure state-of-the-art facility
Huddersfield pharmaceutical company Thornton & Ross is expanding, with a new seven-figure state-of-the-art facility due to open at the beginning of January.
>> News Archive